Drug Recall Enforcement Reports
What are the Drug Enforcement Reports?
All drug recalls are monitored by the Food and Drug Administration (FDA) and are included in the Enforcement Report once they are properly classified. The FDA will determine if a firm's removal or correction actions of a marked product meet the requirements to be considered a "recall". The FDA will also determine the public hazard assessment and a recall classification will be published in the Enforcement Report.
The Drug Enforcement Reports included in this listing was last updated on August 07, 2026 and include a total of 17860 recall reports.
| Recall Number | Recall Initiation Date | Product Description | Recall Reason | Recall Firm / Quantity | Recall Classification | Status |
|---|---|---|---|---|---|---|
| D-1001-2016 | 05-17-2016 | METHYLCOBALAMIN 5MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-0992-2016 | 05-17-2016 | LEVOCARNITINE 100MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-0997-2016 | 05-17-2016 | MB 12/HXB 12/FA/P5P/(LIDO 0.1 %), 2MG/2MCi/20MG/6.5MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-1011-2016 | 05-17-2016 | TESTOSTERONE CYPIONATE 100MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-0998-2016 | 05-17-2016 | M.l.C./B5/B6 25 MG/50MG/25MG/10MG/10MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / N/A | Class II | Terminated |
| D-1006-2016 | 05-17-2016 | QUAD-MIX #1, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-0980-2016 | 05-17-2016 | ATROPINE SULFATE 0.5% Ophthalmic Drops, packaged in 5mL droppers, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (All Products) | Class II | Terminated |
| D-1009-2016 | 05-17-2016 | SUPER TRI-MIX #1, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-1019-2016 | 05-17-2016 | TRI-MIX # 4, packaged in 5 mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-0989-2016 | 05-17-2016 | 1-HCG 2000 IU/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-0988-2016 | 05-17-2016 | 1-HCG 1000 IU/ML, packaged in 5mL and 10mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-1015-2016 | 05-17-2016 | TESTOSTERONE CYPIONATE 200MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-0983-2016 | 05-17-2016 | ESTRADIOL VALERATE 20MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-1003-2016 | 05-17-2016 | MYERS' COCKTAIL, packaged in 37 mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-0949-2016 | 05-17-2016 | Sulfacetamide Sodium Ophthalmic Solution, USP, 10%, Sterile, Rx Only, 15 mL bottles, Mfd. by: Akorn, Inc., Lake Forest, IL 60045 --- NDC 17478-221-12 | Lack of Assurance of Sterility; some lots failed Antimicrobial Effectiveness Testing on stability | Akorn, Inc. / 57,920 bottles | Class II | Terminated |
| D-0986-2016 | 05-17-2016 | GLUTATHIONE 100MG/ML, packaged in 10 mL vials, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-0993-2016 | 05-17-2016 | L-GLUT/L-ARG/L-CARN; 25MG/100MG/200MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-0987-2016 | 05-17-2016 | GLUTATHIONE 200MG/ML, packaged in 5mL vials, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-0994-2016 | 05-17-2016 | M.l.C. 25MG/50MG/25MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-0982-2016 | 05-17-2016 | ESTRADIOL VALERATE 10MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-1018-2016 | 05-17-2016 | TRI-MIX # 3, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-1013-2016 | 05-17-2016 | TESTOSTERONE CYPIONATE 150MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-1020-2016 | 05-17-2016 | TRI-MIX # 5, packaged in 5 mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 | Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility. | Well Care Compounding Pharmacy / 869 Units (Total All Products) | Class II | Terminated |
| D-1476-2016 | 05-17-2016 | CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15, 1 FL. OZ.LIQ./30 ml bottle within a carton, Clinique Labs., Dist. New York, N.Y., 10022; New York, London W1K 3BQ; Paris, UPC No. 20714-47479-9, Shade 04 (M-N) | Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay. | Clinique International / 1,771,244 bottles for all shades | Class III | Terminated |
| D-1473-2016 | 05-17-2016 | CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15, 1 FL. OZ.LIQ./30 ml bottle within a carton, Clinique Labs., Dist. New York, N.Y., 10022; New York, London W1K 3BQ; Paris, UPC No. 20714-47476-8, Shade 01 (VF-N) | Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay. | Clinique International / 1,771,244 bottles for all shades | Class III | Terminated |
| D-1477-2016 | 05-17-2016 | CLINIQUE moisture surge tinted moisturizer broad spectrum SPF 15, 1 FL. OZ.LIQ./30 ml bottle within a carton, Clinique Labs., Dist. New York, N.Y., 10022; New York, London W1K 3BQ; Paris, UPC No. 20714-48240-4, Shade 05 (D-G) | Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay. | Clinique International / 1,771,244 bottles for all shades | Class III | Terminated |
| D-0976-2016 | 05-16-2016 | Potassium CHLORide added to 5% Dextrose Injection, 20 mEq 250 mL Bag, PharMEDium Services, LLC, 6100 Global Drive, Memphis, TN 38141, NDC 61553-836-11, Service Code 2K5836. | Labeling: Not Elsewhere Classified: Potassium Chloride was printed on Potassium Phosphate label stock thereby having both names on the label of a 250 mL bag of Potassium Chloride. | Pharmedium Services, LLC / 240 bags | Class II | Terminated |
| D-1048-2016 | 05-16-2016 | VP-CH-PNV Prenatal/Postnatal capsules, prenatal supplement, 30-count bottle, Rx only, Manufactured for: Virtus Pharmaceuticals, LLC, Tampa, FL 33619, NDC 69543-224-30 | Defective delivery system: Softgel capsules are leaking. | Virtus Pharmaceuticals, Llc / 1,586 bottles | Class III | Terminated |
| D-1187-2016 | 05-13-2016 | GERMANIUM SESO 100MG/ML (PF), 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 49 mL in Vials | Class II | Terminated |
| D-1186-2106 | 05-13-2016 | GABA 50MG/ML (PF), 50ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 110 mL in Vials | Class II | Terminated |
| D-1196-2016 | 05-13-2016 | L-CARNITINE 250MG/ML (PF), 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 2250 mL in Vials | Class II | Terminated |
| D-1207-2016 | 05-13-2016 | LIPO-INJECTION W/METHYL B12 500 MCG/ML W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-500MCG, LIDOCAINE-10MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 4000 mL in Vials | Class II | Terminated |
| D-1243-2016 | 05-13-2016 | TESTOSTERONE CYP 20 MG/ML W/PRES (BENZYL ETOH 2%), In a) 1ML Vials and b) 3ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 20 mL in Vials | Class II | Terminated |
| D-1185-2016 | 05-13-2016 | FOLIC ACID 10MG/ML W/PRES. (METHYLPARABEN 0.05%, PROPYLPARABEN 0.025% IN NACL, 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 500 mL in Vials | Class II | Terminated |
| D-1239-2016 | 05-13-2016 | TAURINE 50 MG/ML (PF), In a) 1ML Vials, b) 10ML Vials, and c) 20ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 5500 mL in Vials | Class II | Terminated |
| D-1226-2016 | 05-13-2016 | MINOXIDIL 0.5% W/PRES. (BENZYL ETOH 2%), 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 21000 mL in Vials | Class II | Terminated |
| D-1170-2016 | 05-13-2016 | B-COMPLEX WITHOUT B12 (PF) IN NACL 0.9%, B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG/ML, In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 4000 mL in Vials | Class II | Terminated |
| D-1235-2016 | 05-13-2016 | PYRIDOXINE HCL 100MG/ML (PF), In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 2000 mL in Vials | Class II | Terminated |
| D-1217-2016 | 05-13-2016 | METHYL B12 1000MCG/ML IN NACL 0.9% (PF), 2ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 2000 mL in Vials | Class II | Terminated |
| D-1197-2016 | 05-13-2016 | L-CARNITINE 500MG/ML (PF), 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 500 mL in Vials | Class II | Terminated |
| D-1213-2016 | 05-13-2016 | MANGANESE SO4 0.1MG/ML (PF), In a) 2MLVials and b) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 3000 mL in Vials | Class II | Terminated |
| D-1198-2016 | 05-13-2016 | L-GLUTATHIONE 100MG/ML (PF), 10 ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 5000 mL in Vials | Class II | Terminated |
| D-1224-2016 | 05-13-2016 | M.I.C 25/50/50 W/PRES. (BENZYL ETOH 2%) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50/MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 500 mL in Vials | Class II | Terminated |
| D-1232-2016 | 05-13-2016 | PROCAINE 2% (PF), In a) 2ML Vials and b) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1500 mL in Vials | Class II | Terminated |
| D-1212-2016 | 05-13-2016 | MANGANESE CHL 0.1MG/ML PF, 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1000 mL in Vials | Class II | Terminated |
| D-1249-2016 | 05-13-2016 | TRYPTOPHAN 10MG/ML (PF), In a) 10ML Vials and b) 50ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 2000 mL in Vials | Class II | Terminated |
| D-1225-2016 | 05-13-2016 | M.I.C 25/50/50 W/METHYL B12 1MG/PYRIDOXAL 50MG/ML (PF), 1ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 2000 mL in Vials | Class II | Terminated |
| D-1229-2016 | 05-13-2016 | NA ASCORBATE 500MG/ML NON-CORN (PF), In a) 10ML Vials, b) 50ML Vials, and c) 100ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 358000 mL in Vials | Class II | Terminated |
| D-1241-2016 | 05-13-2016 | TESTOSTERONE CYP 100 MG/ML W/PRES (BENZYL ETOH 2%), In a) 1ML Vials, b) 2ML Vials, c) 3ML Vials, and d) 5 ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 500 mL in Vials | Class II | Terminated |
| D-1189-2016 | 05-13-2016 | HYDROGEN PEROXIDE 3% (PF), 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1000 mL in Vials | Class II | Terminated |
| D-1174-2016 | 05-13-2016 | B-COMPLEX W/CYANO B12 W/PRES., (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG, CYANO B12 1MG/ML, In a) 2ML Vials, b) 5MLVials, c) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 62 mL in Vials | Class II | Terminated |
| D-1233-2016 | 05-13-2016 | PROLINE 100MG/ML (PF), 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 60 mL in Vials | Class II | Terminated |
| D-1242-2016 | 05-13-2016 | TESTOSTERONE CYP 200 MG/ML W/PRES (BENZYL ETOH 2%), In a) 1ML Vials, b) 2ML Vials, c) 3ML Vials, d) 4ML, and e) 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 8000 mL in Vials | Class II | Terminated |
| D-1210-2016 | 05-13-2016 | LIPO-INJECTION W/LIDOCAINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PO4-5MG, B-3-50MG, B5-5MG, B6-5MG, CYANO B12-100MCG, METHIONINE 12.5MG, INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE-10MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 14000 mL in Vials | Class II | Terminated |
| D-1205-2016 | 05-13-2016 | LIPO-BOOST W/PRES. (BENZYL ETOH 2%) B1-50MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-52MG, METHYL, B12-500MCG, CARNITINE 50 MG, METHIONINE 12.5MG, INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE 30MG/ML, In a) 3ML Vials and b) 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 65 mL in Vials | Class II | Terminated |
| D-1218-2016 | 05-13-2016 | METHYL B12 5MG/ML (PF) IN NACL 0.9%, 1ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 600 mL in Vials | Class II | Terminated |
| D-1246-2016 | 05-13-2016 | THIAMINE 100 MG/ML, 2ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1000 mL in Vials | Class II | Terminated |
| D-1168-2016 | 05-13-2016 | B-COMPLEX #3 W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 380 mL in Vials | Class II | Terminated |
| D-1221-2016 | 05-13-2016 | M.I.C./B-COMPLEX (PF) B1-50MG;B2-5-PO4-5MG;B3-50MG;B6-5MG; CYANO B12 100MCG; CHOLINE CHL-5MG; INOSITOL-25MG;METHIONINE 12.5MG/ML, 2ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 3000 mL in Vials | Class II | Terminated |
| D-1211-216 | 05-13-2016 | MAGNESIUM CHL 200MG/ML (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 5000 mL in Vials | Class II | Terminated |
| D-1245-2016 | 05-13-2016 | TESTOSTERONE CYP 50 MG/ML W/PRES (BENZYL ETOH 2%), In a) 1ML Vials, b) 2ML Vials, c) 3ML Vials, d) 4ML Vials, and e) 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 150 mL in Vials | Class II | Terminated |
| D-1219-2016 | 05-13-2016 | METHYL B12 10MG/ML W/PRES (BENZALKONIUM 0.01%) IN NACL 0.9%, In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 331 mL in Vials | Class II | Terminated |
| D-1204-2016 | 05-13-2016 | LIPO B CYANO 1MG/ML W/PRES. (BENZYL ETOH 1%) METHIONINE 25MG, INOSITOL 50MG, CHOLINE CHL-50MG, CYANO B-12-100MCG, BENZYL ALCOHOL 1%/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 155 mL in Vials | Class II | Terminated |
| D-1223-2016 | 05-13-2016 | M.I.C B-COMPLEX W/PRES. (BENZYL ETOH 2%) B1-50MG;B2-5-PO4-5MG;B3-50MG;B5-5MG;B6-5MG; CYANO B12 100MCG; CHOLINE CHL-50MG; INOSITOL-25MG;METHIONINE 12.5MG/ML, 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1430 mL in Vials | Class II | Terminated |
| D-1244-2016 | 05-13-2016 | TESTOSTERONE CYP 25 MG/ML W/PRES (BENZYL ETOH 2%), 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 13 mL in Vials | Class II | Terminated |
| D-1178-2016 | 05-13-2016 | DEXPANTHENOL 250MG/ML (PF), In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 3500 mL in Vials | Class II | Terminated |
| D-1248-2016 | 05-13-2016 | TMG 100 MG/ML (PF), 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 85 mL in Vials | Class II | Terminated |
| D-1182-2016 | 05-13-2016 | EDTA DISODIUM 15% (150MG/ML), 20ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 24000 mL in Vials | Class II | Terminated |
| D-1193-2016 | 05-13-2016 | HYDROXY B12 1000MCG/ML IN NACL 0.9% (PF), 1ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 300 mL in Vials | Class II | Terminated |
| D-1208-2016 | 05-13-2016 | LIPO-INJECTION W/METHYL B12 500 MCG/CARNITINE/NO VIT C W/PRES. (BENZYL ETOH 2%) B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-500MCG, LIDOCAINE-10MG, CARNITINE 25MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 7000 mL in Vials | Class II | Terminated |
| D-1253-2016 | 05-13-2016 | ZINC SO4 1MG/ML (PF), 2ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 500 mL in Vials | Class II | Terminated |
| D-1195-2106 | 05-13-2016 | L-CARNITINE 50MG/ML (PF), 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 2000 mL in Vials | Class II | Terminated |
| D-1216-2016 | 05-13-2016 | METHYL B12 10MG/ML (PF) IN NACL 0.9%, 1ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1000 mL in Vials | Class II | Terminated |
| D-1234-2016 | 05-13-2016 | PYRIDOXAL 50 MG/THIAMINE 50 MG/LIDOCAINE 1% NS (PF), 2ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1000 mL in Vials | Class II | Terminated |
| D-1199-2016 | 05-13-2016 | L-PHENYLALANINE 15MG/ML (PF), 50ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 55 mL in Vials | Class II | Terminated |
| D-1227-2016 | 05-13-2016 | MOLYBDENUM 250MCG/ML (PF), 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1000 mL in Vials | Class II | Terminated |
| D-1181-2016 | 05-13-2016 | DMSO 99.9 (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 2218 mL in Vials | Class II | Terminated |
| D-1254-2016 | 05-13-2016 | HCL 2MG/ML (PF), 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1000 mL in Vials | Class II | Terminated |
| D-1230-2016 | 05-13-2016 | NANDROLONE DEC 200MG/ML W/PRES. (BENZYL ETOH 10%), In a) 2ML Vials, b) 4ML Vials, and c) 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 400 mL in Vials | Class II | Terminated |
| D-1236-2016 | 05-13-2016 | PYRIDOXINE HCL 100MG/ML W/PRES (BENZYL ETOH 0.02%), 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 4000 mL in Vials | Class III | Terminated |
| D-1176-2016 | 05-13-2016 | CALCIUM SODIUM EDTA 300MG/ML (PF), 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 8500 mL in Vials | Class II | Terminated |
| D-1183-2016 | 05-13-2016 | ESTRADIOLVAL 3MG/TEST CYP 35MG/ TEST PROP 35MG/ML W/PRES. (BENZYL ETOH 2%), 3ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 10 mL in Vials | Class II | Terminated |
| D-1238-2016 | 05-13-2016 | SELENIUM 200MCG/ML (PF), 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 884 mL in Vials | Class II | Terminated |
| D-1167-2016 | 05-13-2016 | B-COMPLEX #3 (PF), B1-100MG, B2-2-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 2ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1000 mL in Vials | Class II | Terminated |
| D-1177-2016 | 05-13-2016 | CESIUM CHLORIDE 600MG/ML (PF), 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 506 mL in Vials | Class II | Terminated |
| D-1175-2016 | 05-13-2016 | B-COMPLEX W/METHYL B12/LIDO W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG, LIDOCAINE 1%, METHYL B12 1MG/ML, In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 370 mL in Vials | Class II | Terminated |
| D-1172-2016 | 05-13-2016 | B-COMPLEX 50 IN NACL 0.9% (PF) B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 2ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1000 mL in Vials | Class II | Terminated |
| D-1171-2016 | 05-13-2016 | B-COMPLEX WITHOUT B12 W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 955 mL in Vials | Class II | Terminated |
| D-1231-2016 | 05-13-2016 | NIACINAMIDE 100 MG/ML (PF), In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 104 mL in Vials | Class II | Terminated |
| D-1203-2016 | 05-13-2016 | LIPO-INJECTION W/LIDOCAINE (PF), ASCORBIC ACID 50MG; B1-50MG; B2-5-PO4-5MG; B3-50MG B5-5MG, B6-5MG, CYANO B-12-100MCG, METHIONINE 12.5 MG, INOSITOL 25 MG, CHOLINE CL-25 MG, LIDCAINE 10 MG/ML, 2ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1000 mL in Vials | Class II | Terminated |
| D-1184-2016 | 05-13-2016 | FOLIC ACID 10MG/ML IN NACL (PF), 1ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 250 mL in Vials | Class II | Terminated |
| D-1209-2016 | 05-13-2016 | LIPO-INJECTION W/LIDOCAINE NO METHIONINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PO4-5MG, B-3-50MG, B5-5MG, B6-5MG, CYANO B12-100MCG,INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE-10MG/ML, 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 4000 mL in Vials | Class II | Terminated |
| D-1188-2016 | 05-13-2016 | HYALURONIDASE 500U/ML(PF), 3ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 500 mL in Vials | Class II | Terminated |
| D-1240-2016 | 05-13-2016 | TAURINE 50 MG/ML W/PRES. (BENZALKONIUM CHL 0.01%), 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 10 mL in Vials | Class II | Terminated |
| D-1215-2016 | 05-13-2016 | METHYL B12 1000MCG/ML/PYRIDOXINE 100MG W/PRES. (BENZALKONIUM 0.01%), In a) 1ML Vials and b) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 20 mL in Vials | Class II | Terminated |
| D-1250-2016 | 05-13-2016 | ZINC CHLORIDE 10MG/ML IN NACL 0.29% (PF), 2ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 500 mL in Vials | Class II | Terminated |
| D-1202-2016 | 05-13-2016 | LIPO #4 W/METHYL B12 500 MCG/ML/NO METHIONINE W/PRES (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;B3-30MG; B5-5MG;B6-5MG;METHYL B12 500 MCG; LIDOCAINE 10 MG; INOSITOL-25MG; CHOLINE CHL-25 MG/ML; 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 1000 mL in Vials | Class II | Terminated |
| D-1173-2016 | 05-13-2016 | B-COMPLEX 50 IN NACL 0.9% W/PRES., (BENZYL ETOH 2%), B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 4000 mL in Vials | Class II | Terminated |
| D-1190-2016 | 05-13-2016 | HYDROXY B12 5MG/ML W/PRES (BENZALKONIUM 0.01%), 5ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 210 mL in Vials | Class II | Terminated |
| D-1214-2016 | 05-13-2016 | METHYL B12 1000MCG/ML W/PRES (BENZALKONIUM 0.01% IN NACL 0.9%, In a) 2ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY | Lack of Assurance of Sterility | Medaus, Inc. / 8020 mL in Vials | Class II | Terminated |
